To assess the implementation progress and performance of Gavi’s support for new and underutilized vaccines and health system strengthening efforts, as well as its contribution to improved immunization coverage and equity, Gavi countries engage in regular review processes—either joint appraisals (JAs) or country engagement framework (CEF) reviews.
The Maternal and Child Survival Program (MCSP) is a key immunization partner in many countries and a member of the immunization coordination committee technical working groups. JSI leads the immunization work under MCSP.
This report provides an overview of the MCSP country experiences during the recent Gavi JA and portfolio planning processes, which took place in six MCSP country programs from July–November 2018. Information about these experiences was obtained through questionnaires, which MCSP immunization staff completed in six countries where they participated in the JA or Portfolio Planning process. Follow-up on responses to the surveys occurred by email.
This report summarizes MCSP staff experience and feedback on the JA and portfolio planning processes and centers on the processes themselves—from MCSP's perspective—and highlights key strengths, challenges, and improvements in the process over years past. It then presents recommendations that could be helpful in improving the overall processes in the future.
MCSP is sharing this information with a view toward:
MCSP believes that strengthening the process will benefit country expanded programs on immunization (EPIs) and, by extension, children and families—Gavi's most important stakeholders. JSI/Maternal and Child Survival Program. 2019.
We strive to build lasting relationships to produce better health outcomes for all.
